| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.0049 | 1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.0041 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.00076 | 1 |